Carregant...
Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease
Fabry disease (FD) is a progressive multisystemic disorder, treatable with recombinant enzyme replacement therapy (agalsidase). However, recent studies suggest an endogenous inhibition of agalsidase in patients with FD, as reported for other lysosomal storage diseases. To assess the clinical consequ...
Guardat en:
| Publicat a: | J Am Soc Nephrol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Nephrology
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4696578/ https://ncbi.nlm.nih.gov/pubmed/25933799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014121226 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|